Cor Vasa 2015, 57(4):485-486

Jan Václavík

Jan Václavík
Centrum pro hypertenzi, I. interní klinika - kardiologická, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice Olomouc, Olomouc

Published: August 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Václavík J. Jan Václavík. Cor Vasa. 2015;57(4):485-486.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. R. Cífková, J. Bruthans, V. Adámková, et al., Prevalence základních kardiovaskulárních rizikových faktorů v české populaci v letech 2006-2009. Studie Czech post-MONICA, Cor et Vasa 53 (2011) 220-229. Go to original source...
    2. J.E. Dickerson, A.D. Hingorani, M.J. Ashby, et al., Optimisation of antihypertensive treatment by crossover rotation of four major classes, Lancet 353 (1999) 2008-2013. Go to original source... Go to PubMed...
    3. G. Mancia, R. Fagard, K. Narkiewicz, et al., 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), Journal of Hypertension 31 (2013) 1281-1357. Go to original source... Go to PubMed...
    4. D.A. Calhoun, D. Jones, S. Textor, et al., Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research, Circulation 2008;117:e510-e526. Go to original source... Go to PubMed...
    5. S.D. Persell, Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension 57 (2011) 1076-1080. Go to original source... Go to PubMed...
    6. A. De La Sierra, J. Segura, J.R. Banegas, et al., Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring, Hypertension 57 (2011) 898-902. Go to original source... Go to PubMed...
    7. J. Ceral, V. Habrdova, V. Vorisek, et al., Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy, Hypertension Research 34 (2011) 87-90. Go to original source... Go to PubMed...
    8. B. Strauch, O. Petrák, T. Zelinka, et al., Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis, Journal of Hypertension 31 (2013) 2455-2461. Go to original source... Go to PubMed...
    9. V. Fung, J. Huang, R. Brand, et al., Hypertension treatment in a medicare population: Adherence and systolic blood pressure control. Clinical Therapeutics 29 (2007) 972-984. Go to original source... Go to PubMed...
    10. J. Jin, G.E. Sklar, V. Min Sen Oh, S. Chuen Li, Factors affecting therapeutic compliance: a review from the patient's perspective, Therapeutics and Clinical Risk Management 4 (2008) 269-286. Go to original source... Go to PubMed...
    11. S. Bangalore, G. Kamalakkannan, S. Parkar, F.H. Messerli, Fixed-dose combinations improve medication compliance: a meta-analysis, American Journal of Medicine 120 (2007) 713-719. Go to original source... Go to PubMed...
    12. M.J. Brown, G.T. McInnes, C.C. Papst, et al., Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial, Lancet 377 (2011) 312-320. Go to original source... Go to PubMed...
    13. S. Neldam, M. Lang, R. Jones, Telmisartan and amlodipine single-pill combinations vs amlodipine monotherapy for superior blood pressure lowering and improved tolerability in patients with uncontrolled hypertension: results of the TEAMSTA-5 study, Journal of Clinical Hypertension 13 (2011) 459-466. Go to original source... Go to PubMed...
    14. B.M. Egan, D. Bandyopadhyay, S.R. Shaftman, et al., Initial monotherapy and combination therapy and hypertension control the first year, Hypertension 59 (2012) 1124-1131. Go to original source... Go to PubMed...
    15. P.P. Gerbino, O. Shoheiber, Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents, American Journal of Health-System Pharmacy 64 (2007) 1279-1283. Go to original source... Go to PubMed...
    16. J.M. Neutel, D.H. Smith, P.A. Reilly, The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension, International Journal of Clinical Practice 53 (1999) 175-178. Go to original source... Go to PubMed...
    17. R. Marfatia, W.B. White, H. Schumacher, Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension, International Journal of Hypertension 2012 (2012) 976828. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes